Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11.

Kazuo Sakashita,Nao Yoshida,Hideki Muramatsu,Yoshitoshi Ohtsuka, Kennichiro Watanabe,Miharu Yabe,Harumi Kakuda,Yuko Honda,Tomoyuki Watanabe,Masami Haba,Shigeru Ohmori,Kazuyuki Matsuda,Yuki Yuza,Akiko Saito,Keizo Horibe,Souichi Adachi,Atsushi Manabe

Transplantation and cellular therapy（2023）

引用 0|浏览8

暂无评分

摘要

The JMML-11 study confirms the positive results of previous retrospective analyses. BU + FLU + MEL might become a standard conditioning regimen for patients with JMML.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要